Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) FCF Margin (2020 - 2022)

RAPT Therapeutics (RAPT) has disclosed FCF Margin for 3 consecutive years, with 1778.89% as the latest value for Q2 2022.

  • Quarterly FCF Margin fell 17015.0% to 1778.89% in Q2 2022 from the year-ago period, while the trailing twelve-month figure was 8493.23% through Mar 2023, down 653249.0% year-over-year, with the annual reading at 4689.98% for FY2022, 306971.0% down from the prior year.
  • FCF Margin hit 1778.89% in Q2 2022 for RAPT Therapeutics, up from 2453.51% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 503.29% in Q2 2020 to a low of 2787.7% in Q4 2021.
  • Historically, FCF Margin has averaged 1439.12% across 3 years, with a median of 1248.38% in 2020.
  • Biggest five-year swings in FCF Margin: plummeted -159415bps in 2021 and later crashed -17015bps in 2022.
  • Year by year, FCF Margin stood at 1193.55% in 2020, then crashed by -134bps to 2787.7% in 2021, then soared by 36bps to 1778.89% in 2022.
  • Business Quant data shows FCF Margin for RAPT at 1778.89% in Q2 2022, 2453.51% in Q1 2022, and 2787.7% in Q4 2021.